SARNP (SAP Domain Containing Ribonucleoprotein) is a protein characterized by its N-terminal SAP domain, which is implicated in DNA binding and RNA processing. This protein, also known by alternative names including Cytokine-induced protein of 29 kDa (CIP29), Nuclear protein Hcc-1, and Proliferation-associated cytokine-inducible protein CIP29, plays a critical role in messenger ribonucleoprotein (mRNP) processing . SARNP antibodies are immunological reagents specifically designed to bind to and detect this protein in various experimental contexts, enabling researchers to investigate its expression, localization, and functions in cellular processes.
SARNP antibodies are predominantly produced as polyclonal preparations in rabbit hosts, though variations exist across commercial suppliers. These antibodies have been validated for multiple applications including Western blotting, immunohistochemistry, immunofluorescence, and enzyme-linked immunosorbent assays (ELISA), making them versatile tools for SARNP-focused research .
SARNP plays a crucial role in the assembly and export of messenger ribonucleoprotein (mRNP) complexes. It facilitates this process through interactions with other proteins, particularly DDX39B, which enables the formation of multimers on RNA for efficient mRNP packaging . The protein exhibits intrinsic RNA-binding capabilities and can bind both single-stranded and double-stranded DNA, with a preference for single-stranded forms, highlighting its multifaceted role in nucleic acid interactions .
Recent crystallographic studies have determined the structure of a Tho1/DDX39B/RNA complex, revealing a multivalent interaction mediated by tandem DDX39B interacting motifs in SARNP/Tho1. Importantly, the high-order complex of SARNP and DDX39B is evolutionarily conserved, and human SARNP can engage with five DDX39B molecules . RNA sequencing data from SARNP knockdown cells shows that the most affected RNAs in export are GC-rich, suggesting a specialized role for SARNP in processing these types of transcripts.
SARNP primarily localizes to the nucleus, particularly in nuclear speckles, consistent with its role in RNA processing . It exhibits broad expression across various tissues and cell types. Knockdown studies have demonstrated that SARNP depletion leads to poly(A) RNA accumulation in nuclear speckles, confirming its important role in mRNA export .
Commercial SARNP antibodies undergo validation through multiple methods to ensure specificity and performance across applications. These methods typically include:
Western blotting to confirm recognition of the correct molecular weight protein
Immunohistochemistry with positive and negative tissue controls
Immunofluorescence to assess subcellular localization patterns
Knockdown/knockout validation to demonstrate specificity
Cross-reactivity testing across multiple species
For instance, the Human Protein Atlas project has extensively characterized and validated anti-SARNP antibodies through immunohistochemistry against hundreds of normal and disease tissues and through immunofluorescence to map subcellular localization .
SARNP antibodies have been widely validated for Western blotting applications, typically detecting a band around 29 kDa corresponding to the SARNP protein . For optimal results, most manufacturers recommend dilutions ranging from 1:500 to 1:2000 . Positive control samples commonly used include cell lysates from 293T, HepG2, BxPC-3, U-87MG, and MCF7 cell lines, which express detectable levels of endogenous SARNP .
For tissue and cellular localization studies, SARNP antibodies have been validated for immunohistochemistry (IHC) and immunofluorescence (IF) applications. Recommended dilutions typically range from 1:50 to 1:500 depending on the specific antibody and application . These applications have revealed that SARNP primarily localizes to the nucleus, consistent with its function in RNA processing and export .
In knockdown studies visualized by immunofluorescence, SARNP has been shown to colocalize with the nuclear speckle marker SC35, further supporting its role in mRNA processing within these subnuclear structures .
A significant application of SARNP antibodies involves investigating the protein's role in mRNA export. Research has demonstrated that SARNP knockdown results in the accumulation of poly(A) RNA at nuclear speckles, indicating impaired mRNA export . RNA-sequencing analysis of SARNP-depleted cells has revealed that GC-rich transcripts are particularly affected, suggesting a specialized role for SARNP in processing these types of RNAs.
SARNP plays a crucial role in the assembly of messenger ribonucleoprotein (mRNP) complexes and their subsequent export from the nucleus. The multivalent interaction between SARNP and DDX39B facilitates the formation of high-order complexes on RNA, which is essential for efficient mRNP packaging and export .
RNA sequencing analysis of SARNP-depleted cells has revealed that mRNAs dependent on SARNP for export share specific features, including:
Higher GC content, particularly in coding regions and 3' UTRs
Slightly shorter mRNA and pre-mRNA lengths
Lower exon numbers
Lower mean intron length
These characteristics suggest that SARNP plays a specialized role in the export of specific mRNA subsets, particularly those with high GC content .
SARNP has been linked to several diseases, notably cancer, where its upregulation in response to cytokines suggests a role in cell cycle progression and tumorigenesis . Additionally, alterations in SARNP expression may influence the pathophysiology of neurodegenerative conditions due to its involvement in RNA metabolism and cellular stress responses . The development and application of specific SARNP antibodies have been instrumental in elucidating these disease associations.
Different commercial SARNP antibodies exhibit varying performance characteristics across applications. The following table summarizes reported performance across common applications:
| Supplier | Catalog Number | Western Blot Performance | IHC Performance | IF/ICC Performance | ELISA Performance |
|---|---|---|---|---|---|
| Antibodies-online | ABIN6147381 | Good | Good | Good | Not reported |
| Assay Genie | CAB13701 | Good | Good | Good | Good |
| Antibodies.com | A27923 | Good | Not reported | Good | Not reported |
| Sigma-Aldrich | HPA030903 | Good (0.04-0.4 μg/mL) | Good (1:200-1:500) | Good (0.25-2 μg/mL) | Not reported |
| Proteintech Group | 15798-1-AP | Good | Not reported | Good | Good |
| Atlas Antibodies | HPA030902 | Good | Good | Good | Not reported |
| GeneTex | GTX106633 | Good | Good | Good | Not reported |
While most SARNP antibodies are raised against human SARNP, many exhibit cross-reactivity with orthologs from other species. This cross-reactivity is particularly valuable for comparative studies across model organisms:
| Supplier | Catalog Number | Human | Mouse | Rat | Other Species |
|---|---|---|---|---|---|
| Antibodies-online | ABIN6147381 | Yes | No | No | No |
| Assay Genie | CAB13701 | Yes | No | No | No |
| Antibodies.com | A27923 | Yes | Yes | Yes | No |
| Sigma-Aldrich | HPA030903 | Yes | Yes | Yes | No |
The cross-species reactivity reflects the evolutionary conservation of SARNP structure across species, with certain epitopes being highly conserved .
The development of increasingly specific and sensitive SARNP antibodies continues to drive research into this important protein's function. Several promising research directions include:
Further characterization of SARNP's role in mRNP assembly and export, particularly in relation to specific RNA classes
Investigation of SARNP's potential as a therapeutic target in cancer, given its association with cell proliferation and tumor development
Development of more specific antibodies targeting particular SARNP domains or post-translational modifications
Exploration of SARNP's interactions with additional protein partners beyond DDX39B
Studies of SARNP function in the context of viral infections, as DDX39B has been implicated in viral RNA processing
Recent structural studies providing insights into SARNP's multivalent interaction with DDX39B open new avenues for understanding the protein's role in RNA metabolism and potentially for developing targeted therapeutics that modulate this interaction .